MedPath

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

Completed
Conditions
CRT-D Cardiac Resynchronization Therapy Defibrillator
Implantable Cardioverter Defibrillators
Registration Number
NCT02091011
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The study is to determine the rate and cause of device replacements at 5 years post-implantation. It will assess the battery and device longevity of the Implantable Cardioverter Defibrillators (ICD) and CRT-D Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices. It will also validate the device survival information given in Boston Scientific's Product Performance Report by comparing the pulse generator (PG) survival probability in the study to that presented in the Product Performance Reports (PPR)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1600
Inclusion Criteria
  • Subject has been implanted within 30 days with a commercially available Boston Scientific ICD or a CRT-D device according to current guidelines and/or center's current practice
  • Subject is willing and capable (or appropriate legal representative is willing and capable) of authorizing access to and use of health information as required by an Institution's Institutional Review Board (IRB), Research Ethics Board (REB) or Ethics Committee (EC)
  • Is willing and capable (or appropriate legal representative is willing and capable) of providing authorization/consent for participation in the study.
Exclusion Criteria
  • Subject is unable or unwilling to comply with the study protocol requirements
  • Subject is under the legal age for signing study consent in accordance with state or national law
  • Subject has a life expectancy of less than twelve months
  • Women of childbearing potential who are or might be pregnant at the time of study enrollment (method of assessment upon physician's discretion)
  • Subject on active heart transplant list
  • Subject with any prior pulse generator infection or lead infection which is either systemic or localized
  • Subject received a commercially available Boston Scientific ICD or CRT-D device with a battery capacity of 1.5 amp/hour or less
  • Subject implanted with Boston Scientific's subcutaneous implantable defibrillator system (s-ICD) or has a lead that is under recall/advisory at the time of enrollment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine the rate and cause of all-cause device replacements of Boston Scientific's market-released ICD and CRT-D devices at 5 years post-implantation.5 years
Evaluate the battery survival of Boston Scientific's market-released ICD and CRT-D devices at 5 years post-implantation.5 years

Battery survival is defined as freedom from surgical replacement of the device due to battery depletion.

Secondary Outcome Measures
NameTimeMethod
Determine the rate and cause of all-cause device replacement of Boston Scientific's market-released ICD and CRT-D devices 1, 2, 3 and 4 years post-implantation.1, 2, 3, and 4 years
Evaluate battery survival of Boston Scientific's market-released ICD and CRT-D devices at 1, 2, 3 and 4 years post-implantation.1, 2, 3, and 4 years
Evaluate the device survival of Boston Scientific's market released ICD and CRT-D pulse generators at 5 years post-implantation; and compare it to the survival probability presented in the Product Performance Report (PPR).5 years
Evaluate potential predictors of device battery longevity at 5 years post-implantation.5 years

Trial Locations

Locations (80)

Alabama cardiovascular group

🇺🇸

Birmingham, Alabama, United States

Birmingham Heart Clinic, P.C.

🇺🇸

Birmingham, Alabama, United States

Phoenix Heart, PLLC

🇺🇸

Glendale, Arizona, United States

Pima Heart Physicians PC

🇺🇸

Tucson, Arizona, United States

Southern Arizona VA Health Care System

🇺🇸

Tucson, Arizona, United States

Mercy Clinic Cardiology Physician Plaza

🇺🇸

Rogers, Arkansas, United States

VA Loma Linda Healthcare System

🇺🇸

Loma Linda, California, United States

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Bradenton Cardiology Center

🇺🇸

Bradenton, Florida, United States

Jackson Memorial Hospital, JHS Office of Research

🇺🇸

Miami, Florida, United States

Scroll for more (70 remaining)
Alabama cardiovascular group
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.